Intracranial metastatic esthesioneuroblastoma responsive to temozolomide

J Neurooncol. 2004 Oct;70(1):73-5. doi: 10.1023/b:neon.0000040826.30636.4a.

Abstract

Successful management of a heavily pretreated 58-year-old woman with metastatic esthesioneuoblastoma using temozolomide is reported. There is no standard treatment of this tumors with extra- and intracranial manifestations. The response, long term stability and high quality of life using temozolomide for this tumor entity should be recognized.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use*
  • Esthesioneuroblastoma, Olfactory / drug therapy*
  • Esthesioneuroblastoma, Olfactory / secondary
  • Female
  • Humans
  • Middle Aged
  • Nasal Cavity / pathology*
  • Nose Neoplasms / drug therapy*
  • Nose Neoplasms / pathology
  • Quality of Life
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide